[Treatment of OIA ovarian ascitic epithelioma by oxygen-peritoneum combined with a cytostatic drug (triethylene melamine)].
D000818:Animals; D005260:Female; D006931:Hyperbaric Oxygenation; D007274:Injections, Intraperitoneal; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D010100:Oxygen / Q000627:therapeutic use*; D010529:Peritoneal Cavity; D051381:Rats; D014265:Triethylenemelamine / Q000627:therapeutic use*
D014265:Triethylenemelamine; D010100:Oxygen
Traitement de l'épithélioma ovarien ascitique OIA par oxygénopéritoine, associé au cytostatique (triéthylènemélamine)